echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Two-session sound: eye-bottom screening gate forward target again reduce blinding rate!

    Two-session sound: eye-bottom screening gate forward target again reduce blinding rate!

    • Last Update: 2020-05-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On May 22, the 2020 National Conference "Health Chinese" series of round-table forums hosted by People's Health of the People's Network continuedIn a special forum on the theme of "Accelerating the construction of the national anti-blind system", the National People's Congress representative, the director of the affiliated ophthalmology hospital of Shandong University of Traditional Chinese Medicine, bi Hongsheng, director of the Ophthalmology Institute of Shandong University of Traditional Chinese Medicine, The National People's Congress representative, the director of the First People's Hospital of Xuzhou City, the director of the Institute of Ophthalmology in Xuzhou City, Li Wei, the national representative of the National People's Congress, the director of the ophthalmology hospital of Shandong Province, the head of the ophthalmology division of the Chinese Medical Association, Shi Weiyun, the head of the Ophthalmology Group of the Chinese Medical Association, and the head of the Beijing TongrenWang Ningli, Director of the Hospital Ophthalmology Center, President of the Ophthalmologist Branch of the Chinese Physicians Association and Chairman of the Public Health Ophthalmology Branch of the Chinese Society of Preventive Medicine, was invited to make suggestions on the topic of promoting standardized early screening of eye diseases, calling for accelerating the introduction of innovative eye drugs urgently needed in the clinic, and devoted to solving the urgent medical needs of the vast number of patients with chinese eye disease, accelerating the construction of the Blind System in China, and helping the development of China's eye health prevention and controlit is learned that all kinds of eye diseases, eye disease patients accounted for more than half of all blindness patients, is the leading cause of inversion of blindness, seriously threatening the health and quality of life of the people, is China's promotion of anti-blind ingestion work in a major focusIn the words of Li Wei's representative, "The bottom of the eye is a window into the overall health situation, and an eye examination can alert or judge the severity of many chronic diseases." "
    With the development of China's economy and the extension of life expectancy, the "aging" society common high blood pressure, diabetes, atherosclerosis cardiovascular disease and other chronic diseases, the incidence of the increase, can lead to eye lesionsAt present, the incidence of eye diseases in China is on the rise"The under-eye disease not only leads to visual impairment, but also irreversible blindness, patients can not be re-identified through treatment, seriously affecting the quality of life, but also to the patient's individual, family society has caused a great burden." Therefore, early screening and early treatment of underlying diseases are essential"
    the National Health and Planning Commission 2017 public information shows that China's diabeticpatients on the regular under-eye examination awareness and the degree of receiving standardized ophthalmology treatment still needs to be improvedTherefore, in the early stage of diabetes, hypertension, cardiovascular disease, advanced and other high-risk groups for eye screening, early detection, early treatment opportunities is particularly important, which can also promote early diagnosis and treatment of systemic diseasesBi Hongsheng said: "The saying goes, 'On the treatment of undiseased diseases', from the treatment as the center to health prevention and control as the center, through early detection, early prevention, so that small diseases do not develop into major diseases, which is also a healthy China construction process has always been adhering to the concept." "
    Li Wei further called for the establishment of a standard examination kit for under-eye diseases, including vision, eye pressure, under-eye photography and optical coherent tomography (OCT), and to write them into the guidance documents for the diagnostic and treatment process of the various under-eye norms"All four tests are noninvasive tests that can be done quickly, combining them to identify the vast majority of eye lesionsWe recommend that these four examinations be the first primary examination of the under-eye disease to help doctors tailor individual treatment options to the patient's condition, so that patients can get timely and targeted treatment"
    in addition, for China's more than 80% of patients with diabetes and other chronic diseases in the county and below medical institutions, but more than half of ophthalmologists concentrated in the first- and second-tier cities of the third-tier hospital medical resources imbalance status quo Bi Hongsheng suggested that medical institutions at different levels in urban and rural areas should be linked to the process of early diagnosis and treatment of eye diseases through hierarchical diagnosis and treatment, remote consultation on the Internet and other means, to help patients in the grass-roots counties to detect diseases as early as possible, to solve problems and problems, and to help the basic medical institutions to train specialists in the process of diagnosis and treatment of under-the-eye diseases in addition to eye diseases, the total number of patients with eye surface disease in China is very large, to the quality of life of patients have a profound impact In China, the most frequent ophthalmic diseases are cataracts, glaucoma, diabetic retinopathy, corneal disease, geriatric macular degeneration and high myopia It is worth noting that, unlike diabetic retinopathy, glaucoma caused by irreversible blindness, cataracts, corneal blindness and other eye diseases blinding, can be effectively treated to restore visual quality according to Wang Ningli, according to Wang Ningli, the "13th Five-Year Plan" since the implementation of China's eye disease prevention and control has made leaps in progress In the past 10 years, China's blindness rate has decreased by 25%, cataract surgery coverage has been close to 70%, and as a huimin surgery into the national health insurance, these exciting facts are marked by the vigorous development of the field of ophthalmology treatment in China in recent years, with the country's attention and investment in ophthalmology health, and to step up the construction of ophthalmology medical team at all levels of hospitals, there are currently 1.2 ophthalmologists per 50,000 people in China, exceeding the World Health Organization's average number of ophthalmology staff On the other hand, Shi Weiyun pointed out, "In the domestic ophthalmology new drug development and scientific research work, we still lag behind the international top level in most cases, clinical lack of efficient and safe innovative drugs." "
    because of the lack of innovative drugs, resulting in many patients in the actual diagnosis and treatment process failed to effectively control the disease, followed by poor treatment, due to repeated recurrence and other problems, resulting in increased difficulty in the treatment of disease, but to consume more medical resources, increase the burden of treatment, it is difficult to fundamentally help patients to remove disease problems, improve the quality of life, restore social function since 2017, Thunderball mono-anti-ophthalmology and other innovative drugs into the "National Medical Insurance Drug Catalog" Category B catalog, and throughout the country and even Xinjiang, Inner Mongolia and other remote areas quickly landed practice, to many patients with under-the-eye disease to bring practical benefits Since 2018, the National Drug Review Center has issued two batches of "Clinically UrgentLy Needed Foreign New Drugs List", introducing a variety of rare diseases and cancer treatment areas of new drugs, to people's livelihood and health has brought good news, but the field of ophthalmology of new drugs are still put into effect during this year's two sessions of the National Congress, Shi Weiyun, Wang Ningli and other representatives advocated the "ophthalmological disease treatment drugs into the third batch of clinically urgent need of new drugs abroad list." In Wang Lining's words, "The introduction of advanced technology and innovation is an important way to promote the development of disciplines." The introduction of new drugs at this stage can completely enhance the existing treatment methods of domestic ophthalmology, narrow the gap between domestic and foreign treatment levels, promote the development of related disciplines in China, but also bring patients a new treatment option, so that they can benefit from the international cutting-edge scientific and technological development as soon as possible "
    the world has a succession of high-impact innovative drugs for glaucoma, geriatric macular degeneration, dry eye disease treatment, really bring long-term visual benefits to patients, significantly reduce the rate of blindness, reduce the burden of social care Shi Weiyun pointed out that if more drugs with new mechanism of action can be included in the clinic, it will bring great benefits to the sustainable development of clinical medicine research and development and the in-depth study of pathogenic mechanism.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.